Literature DB >> 26510879

Evaluating the implementation of RxNorm in ambulatory electronic prescriptions.

Ajit A Dhavle1, Stacy Ward-Charlerie2, Michael T Rupp3, John Kilbourne4, Vishal P Amin5, Joshua Ruiz2.   

Abstract

OBJECTIVE: RxNorm is a standardized drug nomenclature maintained by the National Library of Medicine that has been recommended as an alternative to the National Drug Code (NDC) terminology for use in electronic prescribing. The objective of this study was to evaluate the implementation of RxNorm in ambulatory care electronic prescriptions (e-prescriptions).
METHODS: We analyzed a random sample of 49 997 e-prescriptions that were received by 7391 locations of a national retail pharmacy chain during a single day in April 2014. The e-prescriptions in the sample were generated by 37 801 ambulatory care prescribers using 519 different e-prescribing software applications.
RESULTS: We found that 97.9% of e-prescriptions in the study sample could be accurately represented by an RxNorm identifier. However, RxNorm identifiers were actually used as drug identifiers in only 16 433 (33.0%) e-prescriptions. Another 431 (2.5%) e-prescriptions that used RxNorm identifiers had a discrepancy in the corresponding Drug Database Code qualifier field or did not have a qualifier (Term Type) at all. In 10 e-prescriptions (0.06%), the free-text drug description and the RxNorm concept unique identifier pointed to completely different drug concepts, and in 7 e-prescriptions (0.04%), the NDC and RxNorm drug identifiers pointed to completely different drug concepts. DISCUSSION: The National Library of Medicine continues to enhance the RxNorm terminology and expand its scope. This study illustrates the need for technology vendors to improve their implementation of RxNorm; doing so will accelerate the adoption of RxNorm as the preferred alternative to using the NDC terminology in e-prescribing. Published by Oxford University Press on behalf of the American Medical Informatics Association 2015. This work is written by US Government employees and is in the public domain in the US.

Keywords:  E-Prescribing; NDC; RxNorm; electronic prescriptions; quality

Mesh:

Year:  2015        PMID: 26510879      PMCID: PMC4954631          DOI: 10.1093/jamia/ocv131

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  13 in total

1.  Applying the desiderata for controlled medical vocabularies to drug information databases.

Authors:  L M Lau; S H Lam
Journal:  Proc AMIA Symp       Date:  1999

2.  Retail pharmacy staff perceptions of design strengths and weaknesses of electronic prescribing.

Authors:  Olufunmilola Odukoya; Michelle A Chui
Journal:  J Am Med Inform Assoc       Date:  2012-06-29       Impact factor: 4.497

3.  Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup.

Authors:  Jonathan M Teich; Jerome A Osheroff; Eric A Pifer; Dean F Sittig; Robert A Jenders
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

4.  Unrealized potential and residual consequences of electronic prescribing on pharmacy workflow in the outpatient pharmacy.

Authors:  Karen C Nanji; Jeffrey M Rothschild; Jennifer J Boehne; Carol A Keohane; Joan S Ash; Eric G Poon
Journal:  J Am Med Inform Assoc       Date:  2013-10-23       Impact factor: 4.497

5.  Normalized names for clinical drugs: RxNorm at 6 years.

Authors:  Stuart J Nelson; Kelly Zeng; John Kilbourne; Tammy Powell; Robin Moore
Journal:  J Am Med Inform Assoc       Date:  2011-04-21       Impact factor: 4.497

6.  Towards creating the perfect electronic prescription.

Authors:  Ajit A Dhavle; Michael T Rupp
Journal:  J Am Med Inform Assoc       Date:  2014-07-18       Impact factor: 4.497

7.  Standards for medical identifiers, codes, and messages needed to create an efficient computer-stored medical record. American Medical Informatics Association.

Authors: 
Journal:  J Am Med Inform Assoc       Date:  1994 Jan-Feb       Impact factor: 4.497

8.  Electronic prescribing problems reported to the Pharmacy and Provider ePrescribing Experience Reporting (PEER) portal.

Authors:  Ana L Hincapie; Terri Warholak; Ahmed Altyar; Rebecca Snead; Tara Modisett
Journal:  Res Social Adm Pharm       Date:  2013-10-17

9.  Analysis of community chain pharmacists' interventions on electronic prescriptions.

Authors:  Terri L Warholak; Michael T Rupp
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Jan-Feb

10.  Transmitting and processing electronic prescriptions: experiences of physician practices and pharmacies.

Authors:  Joy M Grossman; Dori A Cross; Ellyn R Boukus; Genna R Cohen
Journal:  J Am Med Inform Assoc       Date:  2011-11-18       Impact factor: 4.497

View more
  4 in total

1.  Assessing automated product selection success rates in transmissions between electronic prescribing and community pharmacy platforms.

Authors:  Jennifer Panich; Natalee Larson; Luanne Sojka; Zach Wallace; James Lokken
Journal:  J Am Med Inform Assoc       Date:  2021-01-15       Impact factor: 4.497

2.  Toward a normalized clinical drug knowledge base in China-applying the RxNorm model to Chinese clinical drugs.

Authors:  Li Wang; Yaoyun Zhang; Min Jiang; Jingqi Wang; Jiancheng Dong; Yun Liu; Cui Tao; Guoqian Jiang; Yi Zhou; Hua Xu
Journal:  J Am Med Inform Assoc       Date:  2018-07-01       Impact factor: 4.497

3.  A Quantitative and Qualitative Analysis of Electronic Prescribing Incidents Reported by Community Pharmacists.

Authors:  Ana L Hincapie; Ahmad Alamer; Julie Sears; Terri L Warholak; Semin Goins; Sara Danielle Weinstein
Journal:  Appl Clin Inform       Date:  2019-06-05       Impact factor: 2.342

4.  Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions.

Authors:  Corey A Lester; Allen J Flynn; Vincent D Marshall; Scott Rochowiak; Brigid Rowell; James P Bagian
Journal:  J Am Med Inform Assoc       Date:  2022-08-16       Impact factor: 7.942

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.